PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.26%
Negative revenue growth while ENPH stands at 1.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
22.85%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
64.97%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
64.97%
Operating income growth above 1.5x ENPH's 26.34%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-42.17%
Negative net income growth while ENPH stands at 24.63%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.00%
Negative EPS growth while ENPH is at 21.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-42.80%
Negative diluted EPS growth while ENPH is at 22.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.93%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
250.43%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
86.11%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
3606.18%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
3606.18%
5Y revenue/share CAGR above 1.5x ENPH's 174.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
3606.18%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
1285.43%
10Y OCF/share CAGR above 1.5x ENPH's 176.50%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1285.43%
Positive OCF/share growth while ENPH is negative. John Neff might see a comparative advantage in operational cash viability.
1285.43%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
145.49%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
145.49%
5Y net income/share CAGR at 75-90% of ENPH's 174.41%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
145.49%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.42%
AR growth is negative/stable vs. ENPH's 17.72%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
40.59%
Inventory growth well above ENPH's 20.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.61%
Asset growth above 1.5x ENPH's 2.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.78%
50-75% of ENPH's 9.32%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-149.74%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
15.74%
We expand SG&A while ENPH cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.